華潤醫藥(03320.HK)附屬胃潰瘍仿製注射用藥內地補充申請獲批

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

華潤醫藥(03320.HK)附屬胃潰瘍仿製注射用藥內地補充申請獲批

阿思達克 08-09 17:01

華潤醫藥(03320.HK)公布，旗下海南雙鶴獲得國家藥品監督管理局頒發注射用蘭索拉唑《藥品補充申請批准通知書》，並通過仿製藥質量和療效一致性評價。該藥臨床用於口服療法不適用的伴有出血的胃、十二指腸潰瘍，急性應激潰瘍，急性胃粘膜損傷的治療。

華潤醫藥(03320.HK)

Relevant Stocks

華潤醫藥(03320.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

華潤醫藥(03320.HK)附屬胃潰瘍仿製注射用藥內地補充申請獲批

Services

About Us

Agreement Statement